Japanese Society for Palliative Medicine
News Letter No.59
日本緩和医療学会ニューズレター
May 2013  59
Journal Watch
東北大学大学院 緩和ケア看護学分野  佐藤 一樹
(レビュー担当:宮下 光令、佐藤 一樹、清水 恵)
 
対象雑誌

対象期間:2012年12月から2013年2月刊行分

いわゆる“トップジャーナル”に掲載された緩和ケアに関する最新論文を広く紹介します。

【N Engl J Med. 2012;367(23-26), 2013;368(1-9)】
なし

【Lancet. 2012;380(9857-9859), 2013;381(9860-9867)】
なし

【Lancet Oncol. 2012;13(12), 2013;14(1-2)】
なし

【JAMA. 2012;308(21-24), 2013;309(1-8)】
米国の高齢患者の死亡場所、療養場所とその移動:2000 年〜 2009 年での変化

Teno JM, Gozalo PL, Bynum JP, Leland NE, Miller SC, Morden NE, Scupp T, Goodman DC, Mor V. Change in end-of-life care for Medicare benefi ciaries: site of death, place of care, and health care transitions in 2000, 2005, and 2009.JAMA. 2013;309(5):470-7.

【Arch Intern Med. 2012;172(22), JAMA Intern Med. 2013;173(1-4)】
英国民の経済状況と心理的苦痛の死亡率への影響

Lazzarino AI, Hamer M, Stamatakis E, Steptoe A. The combined association of psychological distress and socioeconomic status with all-cause mortality: a national cohort study. JAMA Intern Med. 2013;173(1):22-7.

オピオイド服用と交通事故外傷の関連
Gomes T, Redelmeier DA, Juurlink DN, Dhalla IA, Camacho X, Mamdani MM. Opioid dose and risk of road trauma in Canada: a population-based study. JAMA Intern Med. 2013;173(3):196-201.

進行肺がん患者に対する早期緩和ケアの介入内容に関する質的研究
Yoong J, Park ER, Greer JA, Jackson VA, Gallagher ER, Pirl WF, Back AL, Temel JS. Early palliative care in advanced lung cancer: a qualitative study. JAMA Intern Med. 2013;173(4):283-90.

【BMJ. 2012;345(7885-7888), 2013;346(7889-7896)】
市民教育と経鼻ナロキソン配布の市民介入によるオピオイド過量服用死に対する効果

Walley AY, Xuan Z, Hackman HH, Quinn E, Doe-Simkins M, Sorensen-Alawad A, Ruiz S, Ozonoff A. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:f174.

【BMJ Support Palliat Care. 2012;2(4)】
肺がん患者のQOL に対する喫煙の影響:系統的レビュー

Rowland C, Eiser C, Rowe R, Danson S. The eff ect of smoking on health-related quality of life in lung cancer patients:a systematic review. BMJ Support Palliat Care. 2012;2(4):312-318.

終末期患者に対するスピリチュアルケア:インタビューと参加観察研究
Shane Sinclair S, Shelley Raffi n Bouchal SR, Harvey Chochinov H, Neil Hagen N, Susan McClement S. Spiritual care:how to do it. BMJ Support Palliat Care. 2012;2(4):319-327.

進行がん患者の抑うつに対するメチルフェニデートの多施設プラセボ対照二重盲検試験
Centeno C, Sanz A, Cuervo MA, Ramos D, Hernansanz S, Gonzalez J, Almaraz MJ, Lama M, Vara F, Nabal M,Pascual A. Multicentre, double-blind, randomised placebo-controlled clinical trial on the effi cacy of methylphenidate on depressive symptoms in advanced cancer patients. BMJ Support Palliat Care. 2012;2(4):328-333.

EUでのがんと慢性疾患による死亡の現状
Hasselaar J, Engels Y, Menten J, Jaspers B, Vissers K. The burden of non-acute dying on society: dying of cancer and chronic disease in the European Union. BMJ Support Palliat Care. 2012;2(4):334-338.

スピリチュアリティーに関するレビュー
Cobb M, Dowrick C, Lloyd-Williams M. Understanding spirituality: a synoptic view. BMJ Support Palliat Care.2012;2(4):339-343.

同種造血幹細胞移植サバイバーの晩期障害とヘルスケアニーズ:質的研究
Hwang JP, Roundtree AK, Giralt SA, Suarez-Almazor M. Late eff ects and healthcare needs of survivors of allogeneic stem cell transplantation: a qualitative study. BMJ Support Palliat Care. 2012;2(4):344-350.

遺伝子変異とオピオイドの有効性の関連
Fladvad T, Fayers P, Skorpen F, Kaasa S, Klepstad P. Lack of association between genetic variability and multiple pain-related outcomes in a large cohort of patients with advanced cancer: the European Pharmacogenetic Opioid Study (EPOS). BMJ Support Palliat Care. 2012;2(4):351-355.

スペインの院内緩和ケアチームの実態調査
Tuca-Rodriguez A, Gomez-Batiste X, Espinosa-Rojas J, Martinez-Munoz M, Codorniu N, Porta-Sales J. Structure, organisation and clinical outcomes in cancer patients of hospital support teams in Spain. BMJ Support Palliat Care. 2012;2(4):356-362.

脳腫瘍患者に対するマッサージ療法のパイロット研究
Pilot study of the impact of massage therapy on sources and levels of distress in brain tumour patients. Keir ST,Saling JR. BMJ Support Palliat Care. 2012;2(4):363-366.

患者による緩和ケアの質評価尺度
Consumer Quality Index Palliative Care.Claessen SJ, Francke AL, Sixma HJ, de Veer AJ, Deliens L. Measuring patients’ experiences with palliative care: the Consumer Quality Index Palliative Care. BMJ Support Palliat Care. 2012;2(4):367-372.

【Ann Intern Med. 2012;157(11-12), 2013;158(1-4)】
ヘロイン服用者へのナロキソン配布による過量服用死に対する費用対効果の推計

Coffi n PO, Sullivan SD. Cost-eff ectiveness of distributing naloxone to heroin users for lay overdose reversal. Ann Intern Med. 2013;158(1):1-9.

【J Clin Oncol. 2012;30(34-36), 2013;31(1-6)】
小児がんでの第T相試験の説明と親の理解

Cousino MK, Zyzanski SJ, Yamokoski AD, Hazen RA, Baker JN, Noll RB, Rheingold SR, Geyer JR, Alexander SC,Drotar D, Kodish ED. Communicating and understanding the purpose of pediatric phase I cancer trials. J Clin Oncol.2012;30(35):4367-72.

英国での死亡前3か月間のオピオイド処方率の年次変化と処方の関連要因
Higginson IJ, Gao W. Opioid prescribing for cancer pain during the last 3 months of life: associated factors and 9-year trends in a nationwide United kingdom cohort study. J Clin Oncol. 2012;30(35):4373-9.

カナダの腫瘍医の専門的緩和ケアサービス紹介に関する認識
Wentlandt K, Krzyzanowska MK, Swami N, Rodin GM, Le LW, Zimmermann C. Referral practices of oncologists to specialized palliative care. J Clin Oncol. 2012;30(35):4380-6.

終末期医療の話し合いの状況と終末期の積極治療の実施の関連
Mack JW, Cronin A, Keating NL, Taback N, Huskamp HA, Malin JL, Earle CC, Weeks JC. Associations Between End-of-Life Discussion Characteristics and Care Received Near Death: A Prospective Cohort Study. J Clin Oncol. 2012;30(35):4387-95.

がんに関連した倦怠感に対する針治療の効果に関するRCT
Molassiotis A, Bardy J, Finnegan-John J, Mackereth P, Ryder DW, Filshie J, Ream E, Richardson A. Acupuncture for cancer-related fatigue in patients with breast cancer: a pragmatic randomized controlled trial. J Clin Oncol. 2012;30(36):4470-6.

終末期輸液の有効性に関するRCT
Bruera E, Hui D, Dalal S, Torres-Vigil I, Trumble J, Roosth J, Krauter S, Strickland C, Unger K, Palmer JL, Allo J,Frisbee-Hume S, Tarleton K. Parenteral hydration in patients with advanced cancer: a multicenter, double-blind, placebo-controlled randomized trial. J Clin Oncol. 2013;31(1):111-8.

がん医療に関する2012年の知見のまとめ
Roth BJ, Krilov L, Adams S, Aghajanian CA, Bach P, Braiteh F, Brose MS, Ellis LM, Erba H, George DJ, Gilbert MR,Jacobson JO, Larsen EC, Lichtman SM, Partridge AH, Patel JD, Quinn DI, Robison LL, von Roenn JH, Samlowski W, Schwartz GK, Vogelzang NJ. Clinical cancer advances 2012: annual report on progress against cancer from the american society of clinical oncology. J Clin Oncol. 2013;31(1):131-61.

非ホジキンリンパ腫の長期サバイバーのQOLの経時変化
Smith SK, Mayer DK, Zimmerman S, Williams CS, Benecha H, Ganz PA, Edwards LJ, Abernethy AP. Quality of life among long-term survivors of non-Hodgkin lymphoma: a follow-up study. J Clin Oncol. 2013;31(2):272-9.

ビデオの意思決定支援ツールによる進行がん患者の心肺蘇生の意向に対する有効性に関するRCT
Volandes AE, Paasche-Orlow MK, Mitchell SL, El-Jawahri A, Davis AD, Barry MJ, Hartshorn KL, Jackson VA,Gillick MR, Walker-Corkery ES, Chang Y, Lopez L, Kemeny M, Bulone L, Mann E, Misra S, Peachey M, Abbo ED,Eichler AF, Epstein AS, Noy A, Levin TT, Temel JS. Randomized controlled trial of a video decision support tool for cardiopulmonary resuscitation decision making in advanced cancer. J Clin Oncol. 2013;31(3):380-6.

終末期のスピリチュアルケアに関する患者・看護師・医師の認識
Balboni MJ, Sullivan A, Amobi A, Phelps AC, Gorman DP, Zollfrank A, Peteet JR, Prigerson HG, Vanderweele TJ, Balboni TA. Why is spiritual care infrequent at the end of life? Spiritual care perceptions among patients, nurses, and physicians and the role of training. J Clin Oncol. 2013;31(4):461-7.

転移性非小細胞肺がん患者に対する緩和的放射線治療の実態調査
Chen AB, Cronin A, Weeks JC, Chrischilles EA, Malin J, Hayman JA, Schrag D. Palliative Radiation Therapy Practice in Patients With Metastatic Non-Small-Cell Lung Cancer: A Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) Study. J Clin Oncol. 2013;31(5):558-64.

ASCO statement:質の高いがんサバイバーケア
McCabe MS, Bhatia S, Oeffi nger KC, Reaman GH, Tyne C, Wollins DS, Hudson MM. American society of clinical oncology statement: achieving high-quality cancer survivorship care. J Clin Oncol. 2013;31(5):631-40.

進行肺がん患者の外来カルテへの急変時対応の記載の促進方法に関する介入研究
Temel JS, Greer JA, Gallagher ER, Jackson VA, Lennes IT, Muzikansky A, Park ER, Pirl WF. Electronic prompt to improve outpatient code status documentation for patients with advanced lung cancer. J Clin Oncol. 2013;31(6):710-5.

進行がん患者の倦怠感に対する看護師主導の身体症状のモニタリング・治療プロトコルでの介入に関するRCT
de Raaf PJ, de Klerk C, Timman R, Busschbach JJ, Oldenmenger WH, van der Rijt CC. Systematic monitoring and treatment of physical symptoms to alleviate fatigue in patients with advanced cancer: a randomized controlled trial. J Clin Oncol. 2013;31(6):716-23.

がん患者の心理的苦痛やQOL に対する精神腫瘍学的介入の有効性:系統的レビュー
Faller H, Schuler M, Richard M, Heckl U, Weis J, Kuff ner R. Eff ects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: systematic review and meta-analysis. J Clin Oncol. 2013;31(6):782-93.

【Ann Oncol. 2012;23(12), 2013;24(1-2)】
がん患者のQOL が化学療法の治療前・治療中・治療後で異なるか

Ediebah DE, Coens C, Maringwa JT, Quinten C, Zikos E, Ringash J, King M, Gotay C, Flechtner HH, Schmucker von Koch J, Weis J, Smit EF, Kohne CH, Bottomley A. Eff ect of completion-time windows in the analysis of health-related quality of life outcomes in cancer patients. Ann Oncol. 2013;24(1):231-7.

ホジキンリンパ腫サバイバーの晩期障害によるQOL への影響
Khimani N, Chen YH, Mauch PM, Recklitis C, Diller L, Silver B, Ng AK. Infl uence of new late eff ects on quality of life over time in Hodgkin lymphoma Survivors: a longitudinal survey study. Ann Oncol. 2013;24(1):226-30.

臨床試験参加に関する話し合いの有無に対する患者と医療者での認識の違い
Bernhard J, Aldridge J, Butow PN, Zoller P, Brown R, Smith A, Juraskova I. Patient-doctor agreement on recall of clinical trial discussion across cultures. Ann Oncol. 2013;24(2):391-7.

進行がん患者の予後予測の正確性:患者と医療者による予測の比較
Gwilliam B, Keeley V, Todd C, Roberts C, Gittins M, Kelly L, Barclay S, Stone P. Prognosticating in patients with advanced cancer--observational study comparing the accuracy of clinicians' and patients' estimates of survival. Ann Oncol. 2013;24(2):482-8.

骨粗しょう症評価尺度SOF による高齢がん患者の生活機能障害のスクリーニング
Luciani A, Dottorini L, Battisti N, Bertuzzi C, Caldiera S, Floriani I, Zonato S, Ferrari D, Foa P. Screening elderly cancer patients for disabilities: evaluation of study of osteoporotic fractures (SOF) index and comprehensive geriatric assessment (CGA). Ann Oncol. 2013;24(2):469-74.

終末期がん患者の予後とQOL に対する補完代替療法の効果に関する韓国のコホート研究
Yun YH, Lee MK, Park SM, Kim YA, Lee WJ, Lee KS, Choi JS, Jung KH, Do YR, Kim SY, Heo DS, Kim HT, Park SR. Effect of complementary and alternative medicine on the survival and health-related quality of life among terminally ill cancer patients: a prospective cohort study. Ann Oncol. 2013;24(2):489-94.

化学療法による末梢神経障害の評価ツールの信頼性と妥当性の検証
Cavaletti G, Cornblath DR, Merkies IS, Postma TJ, Rossi E, Frigeni B, Alberti P, Bruna J, Velasco R, Argyriou AA, Kalofonos HP, Psimaras D, Ricard D, Pace A, Galie E, Briani C, Dalla Torre C, Faber CG, Lalisang RI, Boogerd W, Brandsma D, Koeppen S, Hense J, Storey D, Kerrigan S, Schenone A, Fabbri S, Valsecchi MG. The chemotherapyinduced peripheral neuropathy outcome measures standardization study: from consensus to the fi rst validity and reliability fi ndings. Ann Oncol. 2013;24(2):454-62.

固形がん患者での埋め込み型静脈ポートに関連した血流感染の予測因子
Chen IC, Hsu C, Chen YC, Chien SF, Kao HF, Chang SY, Hu FC, Yeh KH. Predictors of bloodstream infection associated with permanently implantable venous port in solid cancer patients. Ann Oncol. 2013;24(2):463-8. Steinmetz T, Tschechne B, Harlin O, Klement B, Franzem M, Wamhoff J, Tesch H, Rohrberg R, Marschner N.Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemia. Ann Oncol. 2013;24(2):475-82.

【Eur J Cancer. 2012;48(18), 2013;49(1-3)】
なし

【Br J Cancer. 2012;107(11-12), 2013;108(1-4)】
なし

【Cancer. 2012;118(23-24), 2013;119(1-4)】
肝臓・膵臓がん患者の症状評価尺度NFHSI-18の開発

Butt Z, Parikh ND, Beaumont JL, Rosenbloom SK, Syrjala KL, Abernethy AP, Benson AB, 3rd, Cella D. Development and validation of a symptom index for advanced hepatobiliary and pancreatic cancers: the National Comprehensive Cancer Network Functional Assessment of Cancer Therapy (NCCN-FACT) Hepatobiliary-Pancreatic Symptom Index (NFHSI). Cancer. 2012;118(23):5997-6004.

進行がん患者とがんサバイバーでの炎症反応と倦怠感の関係
de Raaf PJ, Sleijfer S, Lamers CH, Jager A, Gratama JW, van der Rijt CC. Infl ammation and fatigue dimensions in advanced cancer patients and cancer survivors: an explorative study. Cancer. 2012;118(23):6005-11. Mitchell AJ, Lord K, Slattery J, Grainger L, Symonds P. How feasible is implementation of distress screening by cancer clinicians in routine clinical care? Cancer. 2012;118(24):6260-9.

遺伝性非ポリポーシス結腸がん患者の遺伝子検査に関する意向の関連要因
Kuppermann M, Wang G, Wong S, Blanco A, Conrad P, Nakagawa S, Terdiman J, Ladabaum U. Preferences for outcomes associated with decisions to undergo or forgo genetic testing for Lynch syndrome. Cancer. 2013;119(1):215-25.

外来進行がん患者の疼痛の長期的な変動とその関連要因
Zhu J, Davis RB, Stuver SO, Berry DL, Block S, Weeks JC, Weingart SN. A longitudinal study of pain variability and its correlates in ambulatory patients with advanced stage cancer. Cancer. 2012;118(24):6278-86.
Butt Z, Peipert J, Webster K, Chen C, Cella D. General population norms for the Functional Assessment of Cancer Therapy-Kidney Symptom Index (FKSI). Cancer. 2013;119(2):429-37.

がん治療に関する意思決定支援ツールとツール以外の支援方法の有効性:系統的レビュー
Spiegle G, Al-Sukhni E, Schmocker S, Gagliardi AR, Victor JC, Baxter NN, Kennedy ED. Patient decision aids for cancer treatment: are there any alternatives? Cancer. 2013;119(1):189-200.

前立腺がん治療の意思決定への患者の参加度の関連要因
Song L, Chen RC, Bensen JT, Knafl GJ, Nielsen ME, Farnan L, Wallen EM, Mishel M, Pruthi RS, Mohler JL, Godley PA. Who makes the decision regarding the treatment of clinically localized prostate cancer--the patient or physician?: results from a population-based study. Cancer. 2013;119(2):421-8.

新規にがんと診断された患者での化学療法開始時の治療目標の理解とその関連要因
Lennes IT, Temel JS, Hoedt C, Meilleur A, Lamont EB. Predictors of newly diagnosed cancer patients' understanding of the goals of their care at initiation of chemotherapy. Cancer. 2013;119(3):691-9.

転移性脊椎圧迫に対する放射線治療の適応の評価スコアの開発
Rades D, Hueppe M, Schild SE. A score to identify patients with metastatic spinal cord compression who may be candidates for best supportive care. Cancer. 2013;119(4):897-903.

Close